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From Mice to Men: Genetic Doping in
International Sports
By KRISTIN JO CUSTER*
Introduction
Olympism is a philosophy of life, exalting and combining in a
balanced whole the qualities of body, will and mind. Blending
sport with culture and education, Olympism seeks to create a way
of life based on the joy of effort, the educational value of good
example and respect for universal fundamental ethical principles.'
Passion for sports transcends race, gender, physical disability,
and geographic barriers. Why are so many people, of all ages and
sizes, from countries all over the world, fascinated with sports? Is it
the competition and suspense of not knowing who will win? Is it
admiration of mental toughness and determination? Is it awe of the
physical prowess of athletes? Whatever drives the appeal of sports
often pushes athletes to do whatever it takes to be the best.
This note addresses various legal implications of the rising threat
of genetic doping in international sports, specifically applied to the
Olympic Games. Section I outlines the history of doping, describes
the general emergence of genetic doping in the athletic arena, and
considers the growing pressures on athletes to engage in doping.
Section II examines the hierarchy of authority in international sports,
and Section III describes anti-doping efforts. Section IV examines
issues and unique concerns involved in the fight against genetic
doping, and includes various recommendations for handling these
problems.
*J.D. candidate, May 2007, University of California, Hastings College of the Law.
1. OLYMPIC MOVEMENT MEDICAL CODE, pmbl. § 1 (2006), available at
<multimedia.olympic.org/pdf/en-report-1022.pdf>.
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I. Use of Performance-Enhancing Substances in Sports
A. A History of Doping in International Sporting Events
Although the term "doping" generally evokes thoughts of recent
scandals in sports, the practice of using substances to improve
performance in athletic competition is as old as competitive sport
itself.2 Doping is the deliberate or inadvertent use of a performance-
enhancing substance by an athlete. While it has developed over time
with scientific technology, doping has very primitive roots.3 Ancient
Greek athletes often modified their diets to include food and other
substances known to enhance performance.! Athletes consumed
caffeine, cocaine, strychnine, and alcohol to increase endurance in the
19th century It was not until the 1920s, however, that an athletic
organization took steps to restrict drug use in sports.6
In 1928, the International Amateur Athletic Federation took the
first measure as an International Sport Federation (IF) to ban
doping.7 Although technically banned, doping still continued because
no testing was done to ensure the ban was effective s Other IFs
followed suit in prohibiting doping, but no testing was performed by
any of the organizations.9 Synthetic hormones were invented in the
1930s and their use in sports began in the 1950s, exacerbating doping
problems. °
IFs first began administering tests for doping in World
Championships in 1966 with the International Cycling Union (UCI)
and the Federation Internationale de Football Association (FIFA)."
In 1967 the International Olympic Committee's (IOC) Medical
Commission promulgated its first list of banned substances. 2 The
2. World Anti-Doping Agency, A Brief History of Anti-Doping, at











12. Id.; see also International Olympic Committee, The Medical Commission, at
<www.olympic.org/uk/organisation/commissions/medical/index-uk.asp> (visited Nov.
[Vol. 30:2
From Mice to Men: Genetic Doping in International Sports
1968 Summer Olympic Games in Mexico saw the first drug testing
and disqualification in the modern pentathlon when Swede Hans-
Gunnar Liljenwall tested positive for excessive alcohol. According
to Liljenwall, he had two beers to calm his nerves before the pistol
shooting portion of his event. 4 The Swedish team, after winning the
bronze, was forced to return its medals. Later, in the 1972 Summer
Olympics in Munich, fourteen modern pentathletes tested positive for
tranquilizers.1 6 They were not disqualified, however, because the
substances were not on the IOC's list of banned substances. The
tranquilizers were, nevertheless, banned by the International Modern
Pentathlon Union, the governing IF for the sport.
7
By the 1970s, the use of anabolic steroids was booming,
especially in events requiring great strength, such as weightlifting and
track and field throwing events. 18 Until 1974, no reliable testing
method for steroids existed, even though most IFs had introduced
drug testing by this time.' 9 With the introduction of a dependable
testing method, the number of disqualifications due to drugs
increased dramatically in the late 1970s.20
In the 1980s, a scandal emerged in the international athletic
world which complicated anti-doping efforts: government-sponsored
doping.2' The East German government was behind a doping scandal
and cover-up involving nearly 10,000 athletes.22 The government
implemented "State Plan 14.25," a secret initiative to develop sports
nationwide by providing steroid pills to coaches, who in turn gave
them to unknowing athletes in their daily dose of vitamins. 3 The
8, 2006).
13. International Olympic Committee, Mexico 1968 Olympic Games, at
<www.olympic.org/uk/games/past/index-uk.asp?OLGT=1&OLGY=1968> (visited
Nov. 8,2006).
14. Reference.com Encyclopedia, Han-Gunnar Liljenwall, at








22. Kevin Van Valkenburg, Gene Doping Looms as Next Sports Edge: Boost at
Cellular Level is All but Undetectable, BALTIMORE SUN, Jan. 16, 2005, at 1A.
23. Karen Helmstaedt, History of Doping: Acceptance Tinged with Fear, ASCA
ONLINE ARTICLES, at <www.swimmingcoach.org/articles/9904/9904-6.htm> (visited
Nov. 8, 2006).
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German athletes were also given testosterone injections under the
premise that the injections were "vitamin cocktails."24
The case of Ben Johnson shook the athletic world at the 1988
Seoul Olympics. Olympic authorities stripped Johnson of his gold
medal for the 100-meter event after he tested positive for anabolic
steroids.- His case heightened the world's awareness of the n. e to
rid sports of doping.26
More recently, the 1998 Tour de France marked the eruption of a
major scandal in cycling. French customs arrested Willy Voet, a
soigneur of the Festina cycling team, for the possession of illegal
quantities of prescription drugs and narcotics, including
erythropoietin (EPO), growth hormones, testosterone, and
amphetamines.27 This led to further raids of the team's hotel rooms,
where more doping products were found.28 Cyclists responded with a
"sit-down strike" in which they refused to ride, and some teams quit
the Tour altogether.29 Later, Voet wrote a book revealing many
common doping practices of the cycling world.3" He was criminally
prosecuted and his trial revealed that managers of the Festina team
had organized doping for the riders.3" The team had hired a physician
to regulate steroid use because it was safer for athletes to engage in
doping with medical advice, rather than on their own with no
supervision.32 The team argued that doping was widespread within
the cycling world at the elite level.33 This scandal was the driving
force behind the subsequent creation of the new World Anti-Doping
Agency. 34
24. Id
25. World Anti-Doping Agency, A Brief History of Anti-Doping, supra note 2.
26. Id
27. Wikipedia Online Encyclopedia, Tour de France: Doping Scandals, at
<en.wikipedia.org/wiki/Tour de France#Doping.scandals> (visited Nov. 8, 2006). A
soigneur is a non-riding member of a bicycling team whose role is to provide support
for the riders, which could include transportation and organization of supplies,
preparation of the team's food, post-ride massages, and personal encouragement.
Wikipedia Online Encyclopedia, Bicycling Terminology, at <en.wikipedia.org/wiki/







34. World Anti-Doping Agency, WADA History, at <www.wadaama.org/en/
dynamic.ch2?pageCategory.id=311> (visited Nov. 8, 2006).
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Many new doping techniques and technologies have developed
over the years, including advancements in blood doping and EPO."
The future of performance enhancement, however, lies in the form of
gene manipulation, or "genetic doping." The World Anti-Doping
Agency's 2006 List of Prohibited Methods characterizes genetic
doping as "the non-therapeutic use of genes, genetic elements, or of






Gene therapy treats diseases by replacing, manipulating, or
supplementing nonfunctional genes. It originated when scientists
searched for treatments for diseases such as muscular dystrophy,
diabetes, and other genetically-based illnesses. Studies of gene
therapy have been around for decades, but recent developments have
made gene transfer much more effective.37 Medical successes in this
field have captured the interest of athletes looking for ways to
improve performance potential through gene therapy techniques.
Scientifically, gene therapy involves injecting synthetic genes into
muscle cells, where they become indistinguishable from the receiver's
DNA.18 The synthetic genes work to slow muscle atrophy, speed up
metabolism, and increase muscle mass.39 When tested on mice, gene
therapy produced "marathon mice" that ran further and for a longer
period of time than mice without the therapy.40 The genetic alteration
in mice not only improved endurance, but also kept inactive mice that
were fed a high-fat diet from becoming obese.4' The genes essentially
35. Both blood doping and the use of EPO work to increase the level of oxygen-
carrying haemoglobin in the blood, which in turn increases endurance. World Anti-
Doping Agency, A Brief History of Anti-Doping, supra note 2.
36. World Anti-Doping Agency, The World Anti-Doping Code: The 2006
Prohibited List (International Standard), Prohibited Methods M3, 7, available at
<www.wada-ama.org/rtecontent/document/2006-LIST.pdf> [hereinafter "Prohibited
List"].
37. Rachel Bachman, Researchers Look to Head Off Gene Doping Before It




40. James Reynolds, Genetically Modified Mice that Spell the Age of Athletic
Superhero, THE SCOTSMAN, Aug. 25, 2004, at 9.
41. Id.
20071
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mimic exercise, with no physical effort required .
Dr. Lee Sweeney has experimented with genes that produce
insulin-growth factor one (IGF-1), which helps muscles grow and
repair themselves.43 The genes stimulate muscle growth by producing
more IGF-1 than the body would normally produce, and are carried
into the body by a harmless virus." Such breakthroughs offer hope
for diseases of the metabolism, such as obesity and heart disease, but
also serve as a powerful temptation for athletes looking to add muscle
quickly and increase endurance.45
Although gene therapy has evolved significantly in recent years,
the science is still immature in its application to humans.46 Gene
therapy is very early in development and is highly experimental.47
Potential adverse effects are unknown."8 Some fear that cancer could
be a long-term side effect, although many athletes may be willing to
take the risk for the short-term gratification the technology could
provide.49 The risks were demonstrated in French clinical trials."
Eleven boys successfully received gene therapy to replace missing
proteins which allowed their immune systems to function properly.
Three of the boys contracted leukemia, one of whom died. Studies
of gene therapy have been conducted mostly in mice, which have
about a two-year lifespan.12 The mice have died before the long-term
effects of the therapy have been discernable." A twenty-year-old
athlete who uses gene therapy to enhance athletic performance,
however, has an exponentially longer life expectancy during which
long-term effects may manifest. 4
42. Id.
43. Van Valkenburg, supra note 22.
44. Id.
45. Reynolds, supra note 40; see also id.




50. Duncan Mackay, The Race Hots Up to Destroy Genetic Monsters: Gene
Doping is the Ultimate in Cheating, THE GUARDIAN (London), Apr. 29, 2005, at 32.
51. Id
52. Thomas H. Murray, Gene Doping and Olympic Sport, PLAY TRUE: AN
OFFICIAL PUBLICATION OF THE WORLD ANTI-DOPING AGENCY, Issue 1 (2005), at 9
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Many geneticists foresee the technology becoming available in
five to ten years,5 while others predict the 2008 Beijing Olympics will
be the first Olympic Games with genetically enhanced athletes. 6 A
March 2006 case in Germany, however, suggests that some athletes
might already be engaging in genetic doping. 7 A German running
coach, Thomas Springstein, was convicted of doping charges and
given a suspended 16-month jail sentence and 150 hours of
community service for giving performance-enhancing drugs to
teenagers. 8 Springstein is also suspected of being involved in genetic
doping. A search of Springstein's e-mail inbox showed references to
Repoxygen, a banned substance meant to be used in gene therapy to
treat patients with anemia. 9 Repoxygen increases the amount of
oxygen the blood can deliver to the muscles by inducing a release of
EPO.6°  Synthetic EPO is already banned among athletes, but
Repoxygen teaches human cells to produce EPO naturally, requiring
no synthetic EPO.6' This raises suspicions about whether genetic
doping took place at the 2006 Torino Olympics, which began just a
few weeks after evidence was presented in Springstein's case.
The science required to perform genetic doping is not very
complicated and could be duplicated by first-year college students,
provided they have enough money to obtain necessary equipment."
Such a lab would only cost approximately $10 million to start,63 and
the demand would be great. Athletes are willing to spend a lot for an
opportunity to improve performance since winning an event usually
leads to greater fame and money. With multi-million dollar contracts
and glory at stake, some athletes may view doping as a smart
investment. Athletes by nature tend to be highly motivated and
55. Van Valkenburg, supra note 22.
56. Interview by King Kaufman with Will Carroll, Salon.com, Sports Daily (May
16, 2005), available at <www.salon.com/news/sports/col/kaufman/2005/05/16/
monday/> [hereinafter "King Kaufman's Sports Daily"]; Mackay, supra note 50.
57. German Coach Suspected of Genetic Doping, DEUTSCHE WELLE, Nov. 2,
2006, at <www.dw-world.de/dw/article/0,2144,1890782,00.html> (visited Nov. 13,
2006) [hereinafter "DEUTSCHE WELLE"].
58. Sun Wire Services, Coach Convicted of Doping, THE TORONTO SUN, Mar. 21,
2006, at S17.
59. DEUTSCHE WELLE, supra note 57.
60. Id.
61. Id.
62. Van Valkenburg, supra note 22.
63. Nikki Dryden, For Power and Glory. State-Sponsored Doping and Athletes'
Human Rights, 13 SPORTS LAW. J. 1, 26 (Spring 2006).
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willing to take risks, and information about gene therapy is easily
found in medical and scientific literature. 6
Genetic doping may be an enticing method for athletes to
enhance performance because current technology does not detect
genetic doping in humans. Since an actual gene is added to the body,
it is nearly indistinguishable fuom naturally occurring genes. 65 This is
unlike traditional doping methods, which are detectable when a
desired substance or hormone is added to the body. Genetic doping
causes the body to naturally produce desired substances. Not only
are the genetic changes nearly undetectable, but they are also
permanent. 66 If an athlete was enhanced by genetic doping, she would
not have to worry about obtaining drugs or steroids, storing them,
hiding them, taking them routinely, suffering side effects, or testing
positive in blood and urine tests.67
Athletes could implement genetic doping in a variety of ways.
Some athletes with injuries in a particular part of the body might use
genetic doping to promote muscle growth in order to speed healing
and repair damaged muscles.68 Others might use it to strengthen a
muscle they consider weak, thus creating an advantage over others
who have untreated weaknesses. 69 Athletes desiring to enhance
performance by increasing their number of red blood cells might
choose to inject themselves, not with EPO itself, as in the past, but
with the gene that produces the EPO, causing the body to naturally
produce more red blood cells.7"
64. See generally CURRENT GENE THERAPY, available at <www.bentham.org/cgt/
index/htm> (visited Nov. 14, 2006); HUMAN GENE THERAPY, available at
<www.liebertpub.com/publication.aspx?pubid=19> (visited Nov. 14, 2006).
65. Owen Slot, Hghs, Lows, and Dangers.- Why Would-be Dopers Need to be
Nippedin the Bud, THE TIMES (London), Feb. 9,2006, at 82.
66. Genetic Doping a Huge Threat, CANBERRA TIMES (Austl.), Feb. 12, 2005, at
B15.
67. Id
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II. The Hierarchy of Anti-Doping Authority in
International Sports
A. International Olympic Committee
Over the last decade, international sporting organizations have
implemented many measures with goals of increasing and unifying
efforts to prevent doping.71 The primary anti-doping authority is the
Olympic Movement, led by the 1OC." The Olympic Movement
groups together all those who agree to follow the Olympic Charter
and recognize the authority of the IOC. Members include IFs, the
National Olympic Committees (NOCs), the Organizing Committees
of the Olympic Games, athletes, judges and referees, associations and
clubs, as well as all other organizations and institutions recognized by
the 1OC.73 The IOC, an international nongovernmental, nonprofit
organization, serves as an umbrella over the Olympic Movement, and
its primary responsibility is to supervise the Olympic Games.74 The
IOC cites among its priorities as encouraging the participation of
women in sports, promoting sports ethics, and protecting athletes.75
The IOC includes various commissions which meet to study
specific subjects and make recommendations. One such commission
is the Medical Commission, created in 1967 to deal with the
increasing problem of doping in sports.76  The Commission's
fundamental goals include protecting the health of athletes,
respecting both medical and sports ethics, and equality for all
competing athletes.77 The IOC Medical Commission also looks for
alternatives to doping, such as sports medicine, biomechanics,
physiology applied to sports, nutrition, and other sports sciences.8
71. Hayden Opie, Eighth Annual Robert F. Boden Lecture: Drugs in Sports and
the Law- Moral Authority, Diversity and the Pursuit of Excellence, 14 MARQ.
SPORTS L.J. 267, 274 (Spring 2004).
72. International Olympic Committee, Olympic Movement, at
<www.olympic.org/uk/organisation/movement/index-uk.asp> (visited Nov. 8, 2006).
73. Id.
74. International Olympic Committee, International Olympic Committee, at
<www.olympic.org/uk/organisation/ioc/index-uk.asp> (visited Nov. 8, 2006).
75. International Olympic Committee, Organisation, at <www.olympic.org/uk/
organisation/ioc/organisation/index-uk.asp> (visited Nov. 8, 2006).
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The Medical Commission also represents the IOC in the World Anti-
Doping Agency's committees.
B. International Sports Federations
IFs are nongovernmental organizations that administer sports at
the world level in affiliation with national federations admiifiistefing
respective sports.79  IFs must conform their statutes, practices, and
activities with the Olympic Charter in order to be recognized by the
IOC and participate in the Olympic Games. 8°  IFs have the
responsibility of managing and monitoring everyday operations of the
world's various sports disciplines, creating rules for the sports,
holding competitions, and choosing criteria for Olympic team
selections. IFs encompass all sports that compete in the summer and
winter Olympics, as well as other recognized sports, ranging from air
sports to orienteering to wushu.'
C National Olympic Committees and Governing Bodies
NOCs promote the fundamental principles of Olympism at a
national level and are committed to the development of sports in
their respective countries. 83 Only a NOC is authorized to select and
send teams and competitors to participate in the Olympics. ' National
Governing Bodies (NGBs) perform a similar role to NOCs in most
countries. During Olympic years, NOCs take over NGB activities,
and in some countries, as in the United States, the NOCs always have
control over the NGBs.86
79. International Olympic Committee, International Sports Federations, at
<www.olympic.org/uk/organisation/if/index-uk.asp> (visited Nov. 8, 2006).
80. Id.
81. Id.
82. Id. Orienteering is a sport involving navigation using maps and compasses,
often while engaging in other physical activities, such as running, biking, and skiing.
See generally International Orienteering Federation, at <www.orienteering.org>
(visited Jan. 4, 2007). Wushu is a sport based on traditional Chinese martial arts. See
generally Wickipedia, at <en.wikipedia.org/wiki/Wushu> (visited Jan. 4, 2007).
83. International Olympic Committee, National Olympic Committees, at
<www.olympic.org/uk/organisation/noc/index-uk.asp> (visited Nov. 8, 2006).
84. Id
85. Michael S. Straubel, Doping Due Process.: A Critique of the Doping Control
Process in International Sport, 106 DICK. L. REV. 523, 532 (2002).
86. Id.
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D. Court of Arbitration for Sport
The IOC recognizes several other organizations, including the
Court of Arbitration for Sport (CAS), which handles legal problems
facing athletes. Many NOCs and all but one Olympic IF recognize
the jurisdiction of the CAS and include arbitration clauses in their
governing statutes which refer disputes to the CAS. 7
E. World Anti-Doping Agency
In 1999, shortly after the doping events that shook the cycling
world, the IOC called for a World Conference on Doping in Sport in
Lausanne, Switzerland, to combat the phenomenon of doping in
sports.88 The Conference produced the Lausanne Declaration on
Doping in Sport, creating the World Anti-Doping Agency (WADA),
which was fully operational by the Sydney Games in 2000.89 WADA
is an independent agency whose mission is to promote and coordinate
the international fight against doping.'
WADA's mission is to coordinate the global fight against doping
with the creation of a three-level World Anti-Doping Program
(WADP)." In 2004, WADA implemented the first level: the World
Anti-Doping Code (the Code). The Code is the core document that
provides the international framework for anti-doping policies, rules,
and regulations within sports organizations and among public
authorities.92  Levels two and three of the WADP are the
International Standards and the Models of Best Practice,
respectively.93 The International Standards deal with the technical
and operational aspects of anti-doping programs, such as testing and
laboratories. The Models of Best Practice offer recommendations
for implementing the Code within rules and regulations of anti-
doping programs and offer model rules, guidelines, and sample forms
87. International Olympic Committee, International Sports Federations, supra
note 79.
88. World Anti-Doping Agency, WADA History, supra note 34.
89. Id.
90. Id
91. World Anti-Doping Agency, Harmonization Through the World Anti-
Doping Program, available at <www.wada-ama.org/rtecontent/document/
PlayTrue 3_2005_ENStructure.pdf> [hereinafter "Harmonization"].
92. World Anti-Doping Agency, Introduction to the Code, at <www.wada-
ama.org/en/dynamic.ch2?pageCategory.id=267> (visited Nov. 8, 2006).
93. Harmonization, supra note 91.
94. Id.
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and instructions.9 The Code and the International Standards are
mandatory for participation in the WADP.96 Every NOC and
virtually every sporting organization has accepted the Code,9" and
most nations have an anti-doping organization to implement the
Code.98 Many governments cannot be legally bound by the Code
since it is a nongoverinnental documcnt. Pursuant to the Code, such
governments have drafted an International Convention Against
Doping in Sport, which the General Conference of UNESCO
adopted in October 2005, to allow formal acceptance of the Code.99
III. The Anti-Doping Regime Prior to Genetic Doping
A. The Application of Anti-Doping Rules
The fight against doping is the number one priority for the
IOC.'0 The IOC President, Jacques Rogge, has established a "zero-
tolerance" policy regarding doping. 1 All athletes participating in the
Olympic Games must comply with the Olympic Charter and the
applicable rules of the IF, as approved by the IOC.l° Notably, the
IOC requires athletes, coaches, instructors, officials, and all medical
and paramedical staff working or dealing with the athletes
participating or preparing for Olympic sports competitions, to comply
in all aspects with the Code. 3 As part of the Code, WADA
95. Id.
96. Id.
97. World Anti-Doping Agency, Code Acceptance, at <www.wada-ama.org/en/
dynamic.ch2?pageCategory.id=270> (visited Nov. 13, 2006).
98. Jessica K. Foschi, Note, A Constant Battle.- The Evolving Challenges in the
International Fight Against Doping in Sport, 16 DUKE J. COMP. & INT'L L. 457, 462-
463 (2006). In the United States the National Anti-Doping Organization (NADO) is
the U.S. Anti-Doping Agency, commonly referred to as the USADA. NADOs are
independent from their NGBs and NOCs, and apply one system of rules to all
athletes, thus promoting equal application of the Code's provisions. Id.
99. World Anti-Doping Agency, Code: Q&A on the Code, at <www.wada-
ama.org/en/dynamic.ch2?pageCategory.id=367> (visited Nov. 13, 2006). UNESCO
stands for the United Nations Educational, Scientific and Cultural Organization. For
more information about this organization, see <www.unesco.org>.
100. International Olympic Committee, RIGHT AGAINST DOPING AND PROMOTION




103. International Olympic Committee, Olympic Charter, 80 (Sept. 1, 2004),
available at <multimedia.olympic.org/pdf/en-report-122.pdf> [hereinafter "Olympic
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promulgates a List of Prohibited Substances and Methods each
year.
The IOC, IFs, and NOCs maintain their respective power and
responsibility to apply these rules in accordance with their own
procedures, and in cooperation with WADA.'5 IFs and NOCs have
the responsibility to determine whether an athlete has violated a rule
outside of the Olympic Games period. During the Olympic Game
period, the IOC holds this responsibility. 16 The IOC, IFs, and NOCs
submit authority for final appeals to the CAS, after their own
procedures have been exhausted. 7 Specific procedures have been
established for the time during Olympic Games competition.'0 8
B. Anti-Doping Testing Procedures During the 2006 Torino
Olympic Games
During the 2006 Torino Olympic Games, anti-doping testing was
carried out by the IOC Medical Commission. An athlete received
notification telling him that he was selected to submit to a doping
control test.'°" The top five athletes in each event were automatically
selected, along with two other randomly selected athletes."' Once the
athlete reported to the drug control station and was identified, he
gave either a urine or blood sample for testing."' If the result was
abnormal and the athlete did not have a Therapeutic Use Exemption,
then the Medical Commission Chairman forwarded the information
to the IOC President." 2 The IOC President immediately appointed a
Disciplinary Commission, and the athlete and the athlete's NOC were
notified and summoned to attend a hearing by the Disciplinary
Commission."' Depending on the situation, either the Disciplinary
Commission or the IOC Executive Board made a decision about
Charter"]; id.
104. World Anti-Doping Agency, The 2007 Prohibited List (International
Standard), available at <www.wada-ama.org/rtecontent/document/
2007_ListEn.pdf>.




109. Id at 3.
110. Id.
111. Id. at 3-4. Torino was the first Olympics where blood samples were taken.
112. Id. at 4.
113. Id.
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whether and how the athlete would be sanctioned. The result was
then forwarded to the athlete and his NOC.11 4 The athlete could then
appeal the decision to the CAS, which has an ad hoc division during
the period of the Olympic Games.15 In order to be eligible for the
Olympics, all athletes must agree that any dispute shall be submitted
• " 1 . _ ' A .1 116
exclusively Lo tle At.3.
C Procedures for Handling Violations During Olympic Games
Once an athlete tests positive for doping, the Chairman of the
Disciplinary Commission may provisionally suspend the athlete until
the Disciplinary Commission or IOC Executive Board pronounces its
decision. "' The Disciplinary Commission may also provisionally
suspend any other person (the athlete's coach, trainer, doctor, etc.)
who is subject to IOC jurisdiction and who may have contributed to
the apparent doping violation. "8 In accordance with the IOC's zero-
tolerance policy, a violation of anti-doping rules automatically leads
to disqualification of the individual result obtained in the
competition, including forfeiture of any medals, points, or prizes."'
The provision is based on strict liability, whereby fault is not
considered in determining a violation. 2' If the violation is found
before participation in a competition or in between competitions at
the Olympic Games, the IOC may declare the athlete ineligible for
future competitions and Olympic Games. 2'
Under the World Anti-Doping Code, most first violations carry a
mandatory period of ineligibility of two years, and a second violation
results in lifetime ineligibility, unless an athlete can show that she
bears no fault or negligence.122 The mandatory period of ineligibility
may be reduced by up to one half if the athlete proves on a balance of
114. Id.
115. Id.
116. Olympic Charter, supra note 103, at 108.
117. International Olympic Committee, ANTI-DOPING RULES APPLICABLE TO THE
XX OLYMPIC WINTER GAMES IN TURIN, 2006 at 12 (Nov. 11, 2005), available at
<multimedia.olympic.org/pdf/en-report-1018.pdf> [hereinafter "TURIN RULES"].
118. Id. at 13.
119. Id. at 14.
120. Id.
121. Id.
122. World Anti-Doping Agency, WORLD ANTI-DOPING CODE, art. 10.2, (2003),
available at <www.wada-ama.org/rtecontent/document/code-v3.pdf>.
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probabilities that she bears no significant fault.' 3 Additionally, the
athlete may be subject to sanctions outside of the Olympics by the
relevant IF.'24 While the IOC does not impose criminal liability,
violators are often criminally prosecuted in many countries.'
S
D. Violations Based on Circumstantial Evidence
An athlete surprisingly does not have to fail a doping control test
to be found in violation of anti-doping rules. 26  Circumstantial
evidence may be enough to sanction an individual for the following
''non-analytical" violations: use or attempted use of a prohibited
substance or method; refusing, or failing without compelling
justification, to submit to sample collection after notification,
violating applicable requirements regarding athlete availability for
out-of-competition testing; tampering, or attempting to tamper, with
any part of doping control; possessing prohibited substances and
methods; and trafficking in any prohibited substance and method.'
27
Additionally, athlete support personnel found to have
administered or attempted to administer a banned substance or
method may also be sanctioned under the Code. Any type of
complicit behavior leading to a violation or an attempt to conceal the
use of prohibited substances or methods is prohibited.' 8
E. Therapeutic Use Exemptions
Athletes who wish to use a prohibited substance or method for a
legitimate medical reason other than simply to enhance performance
may apply for a Therapeutic Use Exemption (TUE). Under the
World Anti-Doping Code, WADA has set forth International
Standards for granting TUEs. 29  WADA has delegated this
responsibility to the appropriate IF for international-level athletes
and to National Anti-Doping Organizations for national-level
athletes and other athletes subject to doping control under the
123. Id. at art. 10.5.
124. FACTSHEET, supra note 100, at 1.
125. Italy to Treat Doping as Criminal Offense at Turin Olympics, TAIPEI TIMES,
Dec. 21, 2005, at 20.
126. World Anti-Doping Agency, PLAY TRUE: THE WORLD ANTI-DOPING CODE -
A GUIDE, issue 3 (2006) at 10-11, available at <www.wada-ama.org/rtecontent/
document/PlayTrue2006_TheCode-En.pdf> [hereinafter "PLAY TRUE 2006"].
127. Id.
128. Id.
129. WORLD ANTI-DOPING CODE, supra note 122, at art. 4.4.
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Code."'3
Requirements for obtaining a TUE are: the athlete would
experience significant health problems without taking the prohibited
substance or method; the therapeutic use of the substance or method
would not produce significant enhancement of performance; and
-e -is.no reasonable th ...- eitic -Alternative ii-ing the otherwise
prohibited substance or method.31 When a TUE is granted, the IF or
National Anti-Doping Organization must report it to WADA.1
32
WADA may then review the granting of any TUE to an athlete who
is included in his National Anti-Doping Organization's Registered
Testing Pool.'33 An athlete who has been denied a TUE may also
request review by WADA, which may reverse the decision.' 34
IV. Battling Genetic Doping
A. The Pressure to Win May Fuel Genetic Doping
Why do so many athletes resort to doping? The increase in
doping over the last few decades may be attributed to a variety of
sociological and psychological factors. First, the greater availability
and greater effectiveness of medications has played a role.135 Society
has generally become more comfortable with daily use of
pharmaceuticals for a range of ailments. Even individuals who are
not ill often try to better themselves physically with substances such
as herbal supplements, weight loss pills, or Botox injections. Drugs
are now more refined and usually have less side effects. For many
athletes, the potential benefits of performance-enhancing drugs
outweigh any potential side effects. Athletes of all ages and stages of
athletic competition desire these drugs. Sports medicine is now an
essential part of an athlete's preparation, especially at elite levels of
competition.' 3
130. Id.
131. World Anti-Doping Agency, International Standard for Therapeutic Use
Exemptions, at <www.wada-ama.org/en/dynamic.ch2?pageCategory.id=373> (visited
Nov. 8, 2006) [hereinafter "TUEs"].
132. WORLD ANTI-DOPING CODE, supra note 122, at art. 4.4.
133. Id.
134. Id.
135. Ivan Waddington, Doping in Sport.: Sociological Aspects, presented to the
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Sports are more about winning than competing. A good effort is
not admirable compared to a winning or record-breaking effort.
From a political perspective, nations have encouraged athletes to
triumph in international athletic competitions because winning
medals is a symbol of both national pride and superiority over other
nations.137 Victorious athletes are treated as national heroes, and are
rewarded as such, sometimes by governments themselves.138 Nations
have gone so far as to hide systematic doping and arrest those who
expose doping scandals. 9 Athletes who win are often rewarded with
sponsorship deals in the form of product endorsements and television
commercials worth millions of dollars, in addition to contracts with
professional sports organizations." °
B. Is Genetic Doping a Fight Worth Fighting?
Should genetic doping even be regulated? Many people and
organizations such as WADA certainly do not want genetic doping to
become a mainstream reality in sports. By labeling genetic
modification as a form of "doping," WADA has shown a negative
perspective toward the practice. Opponents argue that genetic
modification should not be regulated because there is nothing wrong
with it. Competing ethical, legal, and moral arguments exist on both
sides.'
41
Whether genetic doping should be regulated depends on one's
personal view of sports. Individuals who oppose genetic doping often
137. Id. See also Trip Gabriel, China Strains for Olympic Glory, N.Y. TIMES, Apr.
24, 1988, § 6 (Magazine), at 30 (Chinese gymnastics coach says that "sports is just like
diplomacy," and "when we get good marks, it is a window the world can look into
and tell a lot about our country. It can tell we are well fed, we are stabilized
politically, we are developing quickly, for otherwise it would not be possible to train
athletes and be advanced in sports").
138. Id. Gabriel describes Chinese athletes' rewards after winning Olympic
medals: apartments and houses for athletes and family members filled with furniture
and appliances, and celebrity status for a world-champion ping-pong player.
139. Dryden, supra note 63, at 20-21 (describing a 1994 state-sponsored doping
program in Chinese swimming, and the subsequent arrest of the Chinese journalists
who broke the story and were charged with "denigrating the reputation of Chinese
athletes").
140. Waddington, supra note 135, at 3.
141. For an excellent overview on a wide range of ethical arguments regarding
genetic doping presented in this subsection, see Ted Friedmann, Chairman, Potential
for Genetic Enhancements in Sports, Address at the Fifth Meeting of the
Recombinant DNA Advisory Committee (July 11, 2002), available at
<www.bioethics.gov/transcripts/ju102/session4.html>.
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hold a romantic view of sports and believe that the body should be
untainted and success should only be based on hard work and natural
ability. Others view sports as simply entertainment and an
economically viable industry. Proponents of this view tend to believe
that biotechnology and bioengineering should be fully integrated into
sports, and that an athlete's decision to physically alter himself is a
private decision. 42
The public may decide to accept genetic doping as a legitimate
achievement of science and technology, or it may determine that
international sporting bodies have a greater interest in protecting the
health of athletes. In weighing these opposing interests, one might
compare the right of an athlete to permanently alter her body to an
aspiring actor's decision to have cosmetic surgery. Genetic
enhancement may be simply another tool in the quest for success, and
those willing to take more risks and do "whatever it takes" will come
out on top. On the other hand, genetic enhancement may be
considered an invasive, undeveloped science which may have grave
consequences.
It is difficult to imagine a world where both perspectives are fully
satisfied. If the individualistic view - which emphasizes personal
choice - triumphs, other athletes may be deprived of their perceived
right to compete in a natural, drug-free sports world. On the other
hand, athletes who simply compare genetic enhancement to the
development of technically advanced equipment, such as improved
skis or hockey sticks, would perceive an injustice if denied their right
to access that advanced technology. It is important to consider which
matters most: the ultimate end result or the means of achieving that
result.
There is also an inherent discord in international sports between
athletes who have achieved success through hard work and
individuals with a natural gift for athletics. Many argue that everyone
should start on a level playing field, free of performance-enhancing
substances and methods, in order to promote fair play.'43 Others
argue that the playing field is never level because we are not all born
with the same natural athletic abilities, or raised in the same
142. For a variety of arguments that genetic enhancement should be allowed in
sports, see Andy Miah, Genetically Modified Athletes in Athens? Bring Them on,
THE OBSERVER, Aug. 1, 2004, at 9, available at <observer.guardian.co.uklsport/story/
0,6903,1273665,00.html>.
143. King Kaufman's Sports Daily, supra note 56.
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environment, and that, regardless, athletes who make it to the level of
international sports are not "normal."'" Performance-enhancing
measures may be a way to level the playing field and thus promote
fair play.1 45 Sports organizations already make distinctions in an
attempt to level the field. For example, athletes are separated based
on gender, age, physical or mental handicaps, and weight classes.
146
On the other hand, more naturally talented athletes that use
performance-enhancement methods create an even larger gap
between themselves and those less gifted. Some may view genetic
doping as a "competitive" practice since it advances more athletes
who would not otherwise be able to contend at the top to participate
at an international level. Alternatively, others may consider genetic
doping to be an "anti-competitive" practice because athletes who can
afford to purchase new technological advances will not need to strive
for achievement through hard physical work.
While valid arguments exist on both sides of the debate over the
ethical merits of genetic doping in sports, the remainder of this note
assumes that regulation and restriction is needed. This is the view
that international anti-doping authorities have taken.
C. The Race to Detect Genetic Doping
Although WADA does not believe that genetic doping is a
reality quite yet, the organization regards such doping as a huge
threat deserving of attention.1 47  WADA held the Banbury
Conference in New York in 2002 specifically to discuss the issue of
genetic doping. The conference was attended by leaders in both
sports and science. 148  Richard W. Pound, WADA's president,
believes that being proactive, rather than reactive, regarding genetic
doping is imperative.'49 The conference thus aimed to enhance
awareness of genetic doping and to disseminate information between
scientists and members of the sports world, with the overarching goal
of preventing genetic doping.5 As a result, genetic doping made its
144. Id.
145. Id.
146. Denis Oswalt, IOC member, Lecture on The Quest for Equality of Chances
Through Sporting Regulations (Jan. 31, 2003), available at
<multimedia.olympic.org/pdf/ enreport_700.pdf>.
147. PLAY TRUE 2005, supra note 52, at 1.
148. Id
149. Id. at 2.
150. Id.
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debut on WADA's 2003 Prohibited List of Substances and
Methods.'
In 2004, WADA also formed a genetic doping panel composed
of five of the top researchers in various fields of genetics . The panel
advises WADA's Health, Medical and Research Committee to
provide the committee with current information on advances in
genetic doping.'53 WADA is currently sponsoring a number of
projects aimed at the detection of genetic doping. For instance,
WADA has engaged the very individuals who created genetic therapy
to find a way to detect it in genetically doped athletes.'55 In
collaboration with the Karolinska Institute and the Swedish Sports
Confederation, WADA in December of 2005 held a workshop
referred to as the Stockholm Symposium. The workshop
announced the Stockholm Declaration on Gene Doping, which
makes recommendations regarding procedures, progress, and
educational goals.'57
D. Regulating the Science of Gene Therapy
Gene therapy has the potential to save many lives and improve
the quality of life for individuals with a variety of debilitating
diseases. Research involving gene therapy should not be halted as a
result of fear of misuse in the athletic arena. Gene therapy research
does, however, need to be regulated in order to prevent it from
emerging in sports in the form of genetic doping. Results of
WADA's Banbury Conference calls for governments to "expedite the
development of a global social framework for the application of
genetic transfer technologies that address the potential misuse of
these technologies in sport and a publicly stated deadline for the
151. Pound, supra note 147.
152. PLAY TRUE 2005, supra note 52, at 8.
153. Id.
154. For a description of the sponsored projects, see World Anti-Doping Agency,
Gene and Cellular Technologies Applied to Sports, at <www.wada-
ama.org/en/dynamic.ch2?pageCategory.id=347> (visited Nov. 13, 2006).
155. Id.
156. World Anti-Doping Agency, Science & Medicine Overview, at <www.wada-
ama.org/en/dynamic.ch2?pageCategory.id=526> (visited Nov. 13, 2006).
157. Id. To view all Stockholm Declarations, see World Anti-Doping Agency,
The Stockholm Declaration, at <www.wada-ama.org/en/
dynamic.ch2?pageCategory.id=530> (visited Nov. 8, 2006) [hereinafter "Stockholm
Declaration"].
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adoption of that framework.'
5 8
Recommendations agreed upon during the Stockholm
Symposium state:
[E]xtensive and rigorous regulatory mechanisms are needed to
ensure safety of research subjects and patients. Gene transfer
procedures in human beings must:
a) follow accepted national and international codes and principles
governing experimentation and clinical research in human subjects;
and
b) be performed strictly in accordance with local and national rules
and regulations for gene transfer into human subjects."9
The United States has stringent rules regarding oversight of gene
transfer studies.'9 All gene transfer studies in humans must be
approved at both local and national levels.' At a local level,
hospitals and institutional committees must approve such studies. At
a national level, the Food and Drug Administration and, in most
cases, the Recombinant DNA Advisory Committee of the National
Institute of Health must approve these studies.6 1 Other countries
where experimental clinical studies are being carried out also regulate
gene transfer therapy. Those countries include England, Germany,
France, Italy, Sweden, Japan, China, and Australia.63
Despite regulations and health concerns, rogue labs will likely
make experimental genetic doping available to athletes.'6'
Unregulated labs may not' be concerned with safety or obtain
informed consent from athletes.6 1 Many believe that the
experimental use of gene therapy technology should be grounds for
punishing those administering such treatment. 66  The Stockholm
Symposium recommends that a lack of compliance with standards
and rules of clinical research and gene transfer procedures should be
considered medical malpractice and/or professional misconduct.'
7
158. PLAY TRUE 2005, supra note 52, at 1.
159. Stockholm Declaration, supra note 157.
160. Pound, supra note 147, at 1.






167. Stockholm Declaration, supra note 157.
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The Stockholm Symposium also recommends developing appropriate
sanction mechanisms for illegal or unethical application of gene
transfer in sports."
The temptation for scientists and doctors to defy regulations and
engage in experimental genetic doping on athletes is immense.
Numerous geneticists working on this technology have received as
many inquiries from athletes and coaches as they have from patients
with muscular dystrophy.169  A number of individuals, including
coaches, trainers, and doctors, have a personal and financial interest
in the performance of each athlete. These individuals will go to great
lengths to advance the success of an athlete and will exploit any
loophole in regulations. The money required to set up a gene therapy
laboratory is not excessive by athletic standards, especially
considering the potential for tremendous payoff.17° A rogue scientist
may do a substandard job of using this technology on athletes because
he is attempting to evade oversight mechanisms and detection by
authorities. 7' As a result, athletes could end up in unsafe labs.72
Strict regulation of gene transfer therapy could actually result in more
rogue labs uninterested in the health of athletes.
If WADA persists in requiring strict regulation of gene therapy
research, however, the regulation should be overseen by one
international body, rather than leaving regulation up to local and
national governments. Like the East German government, some
nations might decide that getting ahead in international competition
is more important than the health of athletes, and thus employ lenient
regulations. Other nations might appear to implement strict
regulations in adherence to international WADA standards, yet still
look the other way when it comes to top athletes. Some Olympians,
therefore, would have greater access to genetic doping if their local
and national rules permit greater access to the technology. Nations
could decide that potential detection is a risk that should be taken in
exchange for political strategy or national pride. Additionally,
athletes could take advantage of a more lenient regulation policy in
another country by traveling to that country, receiving therapy, and
168. Id.
169. Mackay, supra note 50, at 32.
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then returning home to compete undetected.'
E. Testing for Genetically Enhanced A thletes
Currently, genetic doping is virtually undetectable. As
previously mentioned, WADA sponsors a number of research
projects aimed at devising a test for genetic doping.17 Genetically
doped muscles may be detected by biopsy, by taking a slice of the
muscle at the spot of DNA injection. 175 This technique is significantly
more invasive than a urine or blood sample, the current methods used
to detect doping. If a biopsy were the only method for detecting
genetic doping, the IOC and WADA would have to determine
whether athletes should be required to submit to such an invasive test
for Olympic competition. The Olympic Movement Medical Code
claims that "the consent of the athletes is required for the collection,
preservation, analysis and use of any biological sample. '', 76 Many
athletes would not voluntarily consent to invasive biopsy testing
unless they were forced to do so in order to compete at an
international level.
The IOC and WADA would also have to determine when such
testing should be conducted. If testing were done too far in advance
of competition, athletes could still have time to engage in genetic
doping before competition. Because genetic doping can add muscle
mass quickly, athletes could engage in genetic doping shortly before
competition and still experience a significant enhancement,
undetected by international authorities. Alternatively, if testing were
done too close to the time of competition, athletes might not have
sufficient time to recover from an invasive procedure. Such testing
could compromise the performance of athletes and diminish the
overall level of competition. This would not align with the IOC's
interest in fostering a high level of competition. Testing done before
the Olympics also begs the question of who would be tested: a
random sample, those predicted to win, or all athletes?
During the Olympics, specific procedures are followed to test the
173. Arthur C. D'Andrea, Federalizing Bioethics, 83 TEX. L. REV. 1663, 1710
(May 2005).
174. See Brian Alexander, Sports Authorities Fear Gene Doping Not Far Off, at
<www.msnbc.msn.com/id/10628586/page/2/print/l/displaymode/1098/> (visited Nov.
14, 2006) (explains prospective technologies to test for genetic doping).
175. John Goodbody, World Sport Clamps Down Quickly on Latest Doping
Threat, THE TIMES (London), Oct. 1, 2002, at 44.
176. OLYMPIC MOVEMENT MEDICAL CODE, supra note 1, at art. 1, § 3.6.
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top five athletes in an event, plus two other randomly selected
athletes, as described above."' These tests are often conducted in
between competitions when a single athlete is competing in multiple
events, so that violators can be caught and disqualified from further
competition in the middle of the Games. In the case of a biopsy to
detect genetic doping, the test probably could not be admin..istered
mid-Games.
Therefore, until a less invasive method of testing for genetic
doping is devised, the IOC's mission to protect the health of athletes
would seem to disqualify testing through biopsy during the Olympic
Games. However, blood and urine samples extracted from athletes
are owned by the IOC for eight years 78 and the IOC has the right to
reanalyze any sample during that time.179 If science allows for
detection of genetic doping through blood or urine analysis by 2014,
violators who participated in the 2006 Torino Games might be
discovered without having to engage in biopsy testing.
If no viable detection method is ever available, an athlete could
still be banned for genetic doping based only on circumstantial
evidence. Currently, to find an athlete guilty of doping, no blood or
urine sample is necessary.180 Sanctions for a doping violation based on
circumstantial evidence is permitted by the Code's allowance for non-
analytical positives. WADA will have to determine what kind of
circumstantial evidence, if any, would be sufficient to convict an
athlete of genetic doping. Rights of due process, at least in the
United States, are implicated when imposing a sanction for genetic
doping on an athlete without conclusive evidence. The right to
compete could be denied without definitive factual substantiation. If
an athlete quickly gains significant muscle mass, increases his
endurance considerably through hard work, or recovers quickly from
an injury, he may have to worry about suspicion or conviction of
genetic doping. Accusations of doping, whether genetic or not,
almost instantaneously tarnish an athlete's reputation, regardless of
the evidence available.
WADA should promulgate and implement clear, specific, and
177. FACTSHEET, supra note 100, at 3.
178. WORLD ANTI-DOPING CODE, supra note 122, at art. 17.
179. TURIN RULES, supra note 117, at art. 6.5.
180. BBC Sport Winter Olympics 2006, IOC denies Austrian Ban Decision (Feb.
24, 2006), at <news.bbc.co.uk/sportl/hi/other-sports/winter-sports/4730842.stm>
(visited Nov. 14, 2006).
181. Id.
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consistent testing programs (when available) and evidentiary
requirements for genetic doping if it wants to effectively detect
individuals using genetic enhancement methods. Ultimately, if
society perceives testing and sanctioning methods as unfair or
unreliable, people may become disillusioned with the regulation
scheme.182 The key to enforcement and approval of a regulatory
scheme is legitimacy, and without a reliable testing method WADA
will have a difficult time curbing genetic doping. Thus, WADA
should focus its efforts and money on finding a reliable test to control
genetic doping, and then execute the test on a global level. Testing
for genetic doping will probably cost significantly more than testing
for traditional doping methods, so not all national anti-doping
agencies will be able to adequately fund such testing for athletes.183
Furthermore, nations have little incentive to rigorously test their
athletes and then publish results showing their athletes are genetically
enhanced."8 This would evoke a negative public response to the
country's athletes and reputation, in addition to raising questions
about why the country did not prevent the doping."' In order to
avoid unequal application of international regulations, WADA
should compensate for national discrepancies in funding and
technology by instituting a single global solution.
F. Therapeutic Use Exemptions for Genetic Therapy
The original purpose of genetic therapy was to control or cure
serious medical conditions. Consider a hypothetical situation where a
six-year-old boy, Brian, suffers from Duchenne Muscular Dystrophy.
This particular type of muscular dystrophy is a result of mutations in a
gene that regulates dystrophin, a protein involved in maintaining the
integrity of muscle fiber. Brian's doctor informs Brian's parents that
untreated, Brian's disease will progress rapidly, and he probably will
not be able to walk by age 12. He will also need a respirator to
breathe by age 20. The doctor also tells Brian's parents that there is a
new and promising option, where a laboratory-engineered gene for
dystrophin can be introduced into Brian's body by means of a
harmless virus.186 Brian's parents pursue this option, and treatment
182. Opie, supra note 71.
183. Van Valkenburg, supra note 22.
184. PLAY TRUE 2006, supra note 126, at 4.
185. Id
186. For a basic overview of Muscular Dystrophy, see WEBMD, at
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for Brian's muscular dystrophy is extremely effective. Brian not only
retains muscle, but he builds muscle and grows like a normal boy.
Brian's parents let him play sports, and he excels at long-distance
running. He trains hard and becomes stronger. By age 20, when
Brian was expected to breathe only with the aid of a respirator, he is a
world-class long-distance runner. Brian earns an opportunity to
represent the United States at the Summer Olympics, wins the silver
medal in the 10,000-meter event, and is subject to the IOC's anti-
doping testing.
The World Anti-Doping Code espouses that the "non-
therapeutic use of cells, genes, genetic elements, or of the modulation
of gene expression, having the capacity to enhance athletic
performance, is prohibited. 1 87 Drawing a line between "therapeutic"
and "enhancement," however, is virtually impossible."" Because
Brian's gene therapy is therapeutic, he should be allowed to compete
in international competitions. The requirements for obtaining a TUE
are that the athlete would experience significant health problems
without taking the prohibited substance or method, the therapeutic
use of the substance or method would not produce significant
enhancement of performance, and there is no reasonable therapeutic
alternative to the use of the otherwise prohibited substance or
method.' Clearly, Brian would experience a significant health
problem had he not received the genetic therapy. For most diseases
treated with genetic therapy, there usually are not reasonable
treatment alternatives.
Some might argue that allowing an athlete who has undergone
gene therapy to compete in international sports is unfair. If a
muscular dystrophy patient receives genetic therapy to allow his
muscles to function normally, surely he would experience a
"significant enhancement of performance" as compared to an
individual with the same disease who would otherwise only be able to
breathe aided by a respirator. Furthermore, we do not know when an
athlete has been enhanced to a level beyond "normal" muscle
functioning. Do we measure "normal" against a normal Olympic
athlete, normal non-Olympic athletes, or normal non-athletes? Anti-
doping organizations must determine how much gene therapy should
<www.webmd.com/content/article/7/1680_53864.htm> (visited Nov. 8, 2006).
187. PROHIBTED LIST, supra note 36 (emphasis added).
188. D'Andrea, supra note 173, at 1671.
189. TUEs, supra note 131.
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be allowed and whether WADA should grant TUEs for genetic
enhancement at all. Any line drawn to distinguish therapy from
enhancement seems to be arbitrary; however, WADA must draw the
line somewhere based on available scientific data if it is to implement
a consistent standard.'9 °
We can also contrast Brian's therapeutic exemption for gene
therapy with other types of enhancements that are allowed. For
example, a biathlete with less than normal vision could undergo laser
vision correction, resulting in better than normal vision. This athlete
would undoubtedly gain an advantage in the rifle shooting aspect of
the sport, yet this is not a "Prohibited Method" according to WADA.
Brian's gene therapy seems more justified and sympathetic than the
biathlete's vision correction, yet he may be banned from international
sports completely, while the biathlete with nearly super-human vision
would be allowed to compete. Such policies invoke issues of equal
protection of the law, particularly in the United States.
TUEs are currently granted by national anti-doping agencies and
IFs. In order to prevent inconsistencies in an international regulatory
scheme, WADA should be the sole authority in granting TUEs for
gene therapy to international-level athletes. WADA promulgates the
International Standard for granting TUEs, but like any statute, these
standards are open to interpretation. Some IFs and national anti-
doping agencies could interpret these standards broadly while others
may interpret them narrowly. If WADA is determined to keep
genetic doping out of athletics, it should control the granting of all
TUEs for genetic therapy, rather than merely reserving the right to
review other's decisions.
G. Natural Genetic Mutations
Another complication facing detection of, and sanctions for,
genetic doping in athletes is that some individuals are born with
natural genetic mutations that are favorable to athletics. 9' For
example, in 1999 a four-year-old German boy whose myostatin gene
was mutated had twice the muscle mass of the average child his age."
190. Id.
191. Van Valkenburg, supra note 22. See also Alexander, supra note 174, for the
case of Eero Mantyranta, a Finnish cross-country skier banned from competition
because of high levels of EPO. It was later learned that he carried a natural mutation
in the EPO gene which told his body to make more red blood cells.
192. Id.
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Suppose that in 20 years this boy became a world class wrestler. If
testing for genetic doping could not distinguish between a genetic
mutation occurring since birth and one induced later in life, this boy
could be shut out of competition. Even if circumstantial evidence
could prove that the athlete had the characteristics of greater muscle
mass since childhood, he could not prove that it was not a result of
childhood genetic doping.
H Problems with Sanctioning Genetically Doped Athletes
A significant legal concern accompanying genetic doping is that
of proper sanctioning for violators. Genetic doping is permanent.
Once an athlete is genetically doped, the effects of such a procedure
are present for the rest of the athlete's life. Anti-doping authorities,
therefore, would have to ban an athlete for life if adhering to the
espoused zero-tolerance policy. Such a policy would leave no room
for a second chance or an opportunity to repent or come clean, unless
a method was devised to reverse the effects of genetic doping.
Currently, the World Anti-Doping Code promotes a standard two-
year suspension for first-time violators. It does not take into account
the permanent nature of genetic doping. Additionally, before
lifetime ban policies could be imposed, the IOC would have to make
sure that a foolproof test was in place. A false positive test would
have severe consequences, and any procedural or analytical mistake
would immediately be challenged by the athlete's lawyers, due to the
grave consequences of a false positive test.
Another consideration is the type of sanctions that may be
imposed on children of one or more genetically enhanced parents.
Because the new genes become part of an individual permanently, a
genetically doped parent would likely produce genetically superior
children.'93 It does not seem just to permanently ban such a child
from participating in international sports, since the athlete himself
would have done nothing wrong. As genetic enhancement techniques
become available over periods of generations, determining whether
an individual is genetically doped could require testing of athletes'
parents to see whether the athlete has natural mutations or inherited
genetic enhancements. This would invoke further concerns regarding
rights of privacy, due process, and equal protection of parents of
athletes. The IOC would have to decide how to handle these
193. Miah, supra note 142.
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children, and what categories of athletes (naturally mutated or
enhanced through parents) could be justifiably sanctioned.
V. Conclusion
Overall, the IOC has significantly increased its effectiveness in
the fight against doping in international sports through the creation of
WADA and the implementation of stricter testing procedures. The
IOC and WADA will soon, however, face a new hurdle in the
regulation, detection, and prevention of genetic doping. Genetic
doping brings about a unique set of legal, moral, and ethical concerns
that will require the IOC and other Olympic Movement organizations
to make many difficult policy judgments in the fight to preserve the
ideal Olympic "philosophy of life."19 ' Allowing one international
body to create uniform regulations, testing, and standards would
facilitate consistent anti-genetic doping results.9
194. OLYMPIC MOVEMENT MEDICAL CODE, pmbl. § 2, supra note 1.
195. For an argument that the IOC should not impose its ethical and social policies
on nations, and that regulation should not rely on one global authority, see Andy
Miah, "Gene Doping" Set to be the Next Sports Scandal, THE NATION (Thail.), Aug.
20, 2005.
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